Integrating network pharmacology and experimental validation reveals PI3K/AKT as a critical pathway in pachymic acid-induced inhibition of hepatocellular carcinoma
By: Jun Liang, Hongyu Zhang, Shixin Pan, Tao Si, Minzhong Tang and Zheng Peng
Language: English
Accepted on: Oct 11, 2026
Published on: Oct 26, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Jun Liang, Hongyu Zhang, Shixin Pan, Tao Si, Minzhong Tang, Zheng Peng, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.